In this case-based online activity, Miguel-Angel Perales, MD, discusses the graft-versus-leukemia effects of HSCT, emerging data on conditioning and maintenance therapies, and the management of transplant-related complications. Register today!

Patients with TNBC have a poorer prognosis than those who present with HR-positive or HER2-positive disease. This CME/CE-approved discussion on metastatic TNBC with Sara Tolaney, MD, MPH and Sara Hurvitz, MD will evaluate personalized care plans, genetic risk evaluation, and novel therapies.

This online strategy session features a multidisciplinary discussion between Anthony R. Mato, MD, MSCE and Colleen Dorsey, RN, BSN as they discuss risk for TLS, signs and symptoms, as well as prevention and treatment strategies in patients with hematologic malignancies.

Watch this case-based CME/CE-certified recording with Christopher R. Flowers, MD, MS as he discusses emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL.

This case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

How can you improve the treatment outcomes for patients with this rare malignancy? This online activity, led by Morie A. Gertz, MD, MACP and Toni Dubeau, RN, NP, will discuss risk stratification, novel therapeutic approaches, and adverse event management. Start now!

In this online activity, Craig H. Moskowitz, MD and Kami Maddocks, MD discuss factors that increase risk for cHL treatment failure, emerging data on the treatment of newly diagnosed and relapsed/refractory cHL, and assess strategies to manage toxicities associated with therapy.

This case-based discussion on metastatic gastric cancer features Jaffer A. Ajani, MD and Allyson J. Ocean, MD as they examine individualized treatment selection, novel therapies, and adverse event management. Register to get started today!

In this case-based activity, Alicia K. Morgans, MD, MPH and Tanya Dorff, MD discuss predictive and prognostic markers, recent findings, novel treatments, and supportive care plans for patients with castration-resistant prostate cancer.